Table 2.
Demographic and clinical data for the invasive melanomas diagnosed in 2016–2018 (n = 301).
| Demographic and clinical data | Number (%) |
|---|---|
| Healthcare provider | |
| Department of dermatology | 79 (26.2) |
| Other hospital departments | 67 (22.3) |
| General practitioners | 105 (34.9) |
| Others outside of the hospital | 50 (16.6) |
| Clinical diagnosis on pathology form | |
| Melanoma | 114 (37.9) |
| DDx melanocytic lesion | 55 (18.3) |
| Various tumour types | 51 (16.9) |
| Basal cell carcinoma | 10 (3.3) |
| Benign lesion | 7 (2.3) |
| No specific diagnosis | 64 (21.3) |
| Gender | |
| Men | 151 (50.2) |
| Women | 150 (49.8) |
| Treatment | |
| Local excision | 239 (79.4) |
| Biopsy | 62 (20.6) |
| Location | |
| Trunk | 170 (56.5) |
| Lower extremity | 48 (16.0) |
| Upper extremity | 47 (15.6) |
| Head and neck | 16 (5.3) |
| Face | 18 (6.0) |
| Ear | 1 (0.3) |
| Missing information | 1 (0.3) |
| Morphological subtype | |
| SSM | 126 (41.9) |
| LMM | 16 (5.3) |
| NM | 14 (4.7) |
| Other types | 9 (3.0) |
| Not stated | 136 (45.1) |
| T-stage | |
| pT1 | 194 (64.5) |
| pT2 | 48 (15.9) |
| pT3 | 25 (8.3) |
| pT4 | 29 (9.6) |
| pTx | 5 (1.7) |
DDx: differential diagnosis; LMM: lentigo malignant melanoma; NM: nodular melanoma; SSM: superficial spreading melanoma.